Regression of CD8+ pseudolymphoma after HIV antiviral triple therapy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12833028.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To our knowledge, we report the first case of improvement of HIV-associated cutaneous CD8(+) pseudolymphoma with highly active antiretroviral therapy. This favors the hypothesis of a reactive cutaneous infiltration by HIV-specific cytotoxic T cells in this disease.
Medical subject headings
- Antiretroviral Therapy, Highly Active
- CD8-Positive T-Lymphocytes
- Lymphoma, AIDS-Related
- Lymphoma, T-Cell, Cutaneous
- Pseudolymphoma
- Skin Neoplasms